Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso
Last updated 29 julho 2024
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
IJMS, Free Full-Text
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage infection is inhibited by the type III CRISPR-Cas system. A.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbo phage PCH45 evades type I, but not type III, CRISPR–Cas
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A Jumbo Phage Forms a Nucleus-like Compartment to Evade Bacterial Defense Systems
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection - ScienceDirect
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Frontiers Biological and Molecular Characterization of a Jumbo Bacteriophage Infecting Plant Pathogenic Ralstonia solanacearum Species Complex Strains
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection

© 2014-2024 hellastax.gr. All rights reserved.